New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix’s RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In TherapyBusiness
Black Knight: February Uptick in Early-Stage Delinquencies Drives First Increase in Past- Due Mortgages in Nine Months; Foreclosure Starts Fall 24% Following January SpikeBusiness
Michigan Man Charged With Using $1 million in Covid-Relief Loans To Purchase Seaview Condominium in Beirut, LebanonUncategorized
